| Segment Information |
13. Segment Information
The Company’s operations involve the development and usage, including licensing, of its proprietary DehydraTECH Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information, supplemented by revenue information by category of alternative health consumer products and technology licensing, to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property and B2B Products. Licensing revenues are significantly concentrated on one licensee.
Six Months Ended February 28, 2023 |
|
IP Licensing |
|
|
B2B |
|
|
Corporate |
|
|
Consolidated Total |
|
Revenue |
|
$ |
80,310 |
|
|
$ |
30,300 |
|
|
$ |
25,881 |
|
|
$ |
136,491 |
|
Cost of goods sold |
|
|
- |
|
|
|
(18,753 |
) |
|
|
- |
|
|
|
(18,753 |
) |
Operating expenses |
|
|
(45,758 |
) |
|
|
(183,030 |
) |
|
|
(2,968,894 |
) |
|
|
(3,197,682 |
) |
Segment income (loss) |
|
$ |
34,552 |
|
|
$ |
(171,483 |
) |
|
$ |
(2,943,013 |
) |
|
$ |
(3,079,944 |
) |
Total assets |
|
$ |
114,546 |
|
|
$ |
72,929 |
|
|
$ |
4,667,504 |
|
|
$ |
4,854,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended February 28, 2022 |
|
IP Licensing |
|
|
B2B |
|
|
Corporate |
|
|
Consolidated Total |
|
Revenue |
|
$ |
16,160 |
|
|
$ |
17,512 |
|
|
$ |
10,858 |
|
|
$ |
44,530 |
|
Cost of goods sold |
|
|
- |
|
|
|
(11,957 |
) |
|
|
- |
|
|
|
(11,957 |
) |
Operating expenses |
|
|
(1,367,712 |
) |
|
|
(190,611 |
) |
|
|
(1,926,406 |
) |
|
|
(3,484,729 |
) |
Segment loss |
|
$ |
(1,351,552 |
) |
|
$ |
(185,056 |
) |
|
$ |
(1,915,548 |
) |
|
$ |
(3,452,156 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
939,790 |
|
|
$ |
87,291 |
|
|
$ |
10,387,483 |
|
|
$ |
11,414,564 |
|
|
Capital Asset by Region
Six Months Ended February 28, 2023
|
|
Cost
US
|
|
|
Addition US |
|
|
Net Balance
US
|
|
|
Cost
Canada
|
|
|
Addition Canada |
|
|
Net Balance Canada |
|
|
Total Net Balance |
|
Leasehold Improvements |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
259,981 |
|
|
$ |
- |
|
|
$ |
38,277 |
|
|
$ |
38,277 |
|
Computers |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
70,781 |
|
|
|
- |
|
|
|
6,991 |
|
|
|
6,991 |
|
Furniture & Fixtures |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
31,126 |
|
|
|
- |
|
|
|
5,079 |
|
|
|
5,079 |
|
Lab Equipment |
|
|
140,487 |
|
|
|
33,748 |
|
|
|
127,880 |
|
|
|
193,185 |
|
|
|
- |
|
|
|
123,194 |
|
|
|
251,074 |
|
|
|
$ |
140,487 |
|
|
$ |
33,748 |
|
|
$ |
127,880 |
|
|
$ |
555,073 |
|
|
$ |
- |
|
|
$ |
173,541 |
|
|
$ |
301,421 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Asset by Region
Year Ended August 31, 2022
|
|
Cost
US
|
|
|
Addition
US
|
|
|
Net Balance
US
|
|
|
Cost
Canada
|
|
|
Addition Canada |
|
|
Net Balance Canada |
|
|
Total Net Balance |
|
Leasehold Improvements |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
259,981 |
|
|
$ |
- |
|
|
$ |
65,296 |
|
|
$ |
65,296 |
|
Computers |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
63,964 |
|
|
|
6,817 |
|
|
|
9,357 |
|
|
|
9,357 |
|
Furniture & Fixtures |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
31,126 |
|
|
|
- |
|
|
|
8,289 |
|
|
|
8,289 |
|
Lab Equipment |
|
|
98,050 |
|
|
|
42,375 |
|
|
|
100,031 |
|
|
|
193,185 |
|
|
|
- |
|
|
|
132,533 |
|
|
|
232,563 |
|
|
|
$ |
98,050 |
|
|
$ |
42,375 |
|
|
$ |
100,031 |
|
|
$ |
548,256 |
|
|
$ |
6,817 |
|
|
$ |
215,475 |
|
|
$ |
315,505 |
|
|